|
Site/Type
|
Protocol Title
|
Total Resection:
Stage I (T1T2, N0) |
ECOG E5597: Chemoprevention using Selenium |
| Stage IB - IIIA (> / =4cm) & completely resected |
ECOG E1505: Adjuvant chemotherapyw with or without Bevacizumab |
| Stage IIIa/IIIb |
RTOG 0617: Standard Dose (60Gy) Radiation Therapy versus High Dose (74Gy) conformal Radiation Therapy with concurrent and consolidation Carboplatin + Paclitaxel |
| Stage IIIB, IV or Recurrent |
ECOG PrE0501: Docetaxel and Carboplatin plus Vandetanib (ZD6474), then maintanence therapy with Placebo or Vandetanib |
| Stage IV-Bronchioalveolar Carcinoma (BAC) or Adenocarcinoma with BAC Features | ECOG E1504: C225 (Cetuximab) |
| Stage IV-2nd line therapy |
CTSU N0723 (MARVEL): Erlotinib versus Pemetrexed |
| Treatment of side effects to the lungs following radiation therapy |
RTOG 0123 Captopril for individuals who have received Radiation Therapy with or without Chemotherapy |
| Positron Emission Tomography (PET) Scan and Lung Cancer | RTOG 0235: Pre and Post treatment assessment, using PET Scans, for locally advanced NonSmall Cell Lung Cancer |